Sullivan Lara

President and CEO, DirectorPyxis Oncology, Inc. (PYXS) · full profile →Form 4 · filed Sep 13, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$63K
Net Open-Market Flow
-$63K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 13, 2023Sell(S)3K$2.27$7K2.6M
Sep 13, 2023Tax withholding(F)185K$2.13$394K2.4M
Sep 12, 2023Sell(S)5K$2.25$11K2.6M
Sep 11, 2023Sell(S)20K$2.27$45K2.6M

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-049366) within minutes of acceptance. Every field above traces to the original document. Verify it directly: